Search

Global Health Watch: Leadership in Flux, Further Cuts to Foreign Aid, a Pandemic Accord

Just three months since the US presidential inauguration, and still more developments affecting the future of HIV prevention, global health leadership, and pandemic preparedness. From African women leaders demanding action to save HIV prevention, to escalating US foreign aid cuts and the fragile progress of WHO’s Pandemic Agreement, this issue break down what advocates need to know now.

Politics and Global Health: The Need for a New, Resilient Architecture

Despite USG Global Health Collapse, Here Are Several Data Trackers To Support Your Advocacy

With the collapse in support from the US Presidential administration in global health, data sources tracking the HIV response have been lost, from HIV incidence and prevalence to PrEP uptake and disparities among key populations and regions of the world.

Global Health Watch: Tariffs, NIH Cuts, Black-led HIV Research Agenda & PEPFAR’s Legacy

This week brought major developments for global health: new tariffs on pharmaceuticals are pending, a court blocks the cap on NIH indirect costs, and worries a leadership vacuum at the CDC is a cause for yet more concern. Amid the chaos, advocates rallied—defending PEPFAR’s legacy in Congress and launching a national Black-centered, Black-led HIV research agenda.

Let’s Talk MPTs: Introducing the Dual Prevention Pill- Lessons Learned and What’s Next for Regulatory, Research, and Rollout

Years Ahead in HIV Prevention Research: Time to Market

This timeline shows the potential time points when the next-generation of HIV prevention options might find their way into new programs.

A Fight for Global Health and Justice: An update on AVAC vs. US State Department

Just two months ago, AVAC led other organizations to sue the US government including the President, the US State Department and USAID, seeking emergency relief from an Executive Order that inhumanely froze all funding for foreign assistance. This case may well help to determine the future of foreign assistance, executive overreach, and the role of evidence, facts, and values in US policy. 

Lawsuit Wins and What’s at Stake

On February 10, AVAC led other organizations to sue  the US government including the President, the US State Department and USAID,  seeking emergency relief from an Executive Order that inhumanely froze all funding for foreign assistance. This case may well help to determine the future of foreign assistance, executive overreach, and the role of evidence, facts, and values in US policy.

AVAC’s Executive Director, Mitchell Warren and Public Citizen Litigator, Lauren Bateman explain these lawsuits and why they matter.

Global Health Watch: CDC, NIH, FDA Hit Hard as HHS Begins Workforce Reductions

This week’s issue covers drastic cuts across the US Department of Health and Human Services (HHS), where a dramatic 20% downsizing effort is underway. The ripple effects are vast—gutting HIV prevention, infectious disease research, and vaccine development, while threatening the stability and viability of the workforce that sustains US public health and biomedical research.

AVAC Condemns HHS Mass Layoffs

AVAC condemns the US administration’s ongoing reduction in force of the US Department of Health and Human Services, which oversees 13 agencies, including the Centers for Disease Control and Prevention, the Food and Drug Administration and the National Institutes of Health.